Bat 60492-0075
Generic: Botulism Antitoxin Heptavalent
Product NDC
60492-0075- Manufacturer
- Emergent Biosolutions Canada Inc
- Dosage Form
- Liquid
- Route
- Intravenous
- Product Type
- Plasma Derivative
- Marketing Start
- March 1, 2013
- Listing Expires
- December 31, 2026
- Application
- BLA125462
Active Ingredients
| Ingredient | Strength |
|---|---|
| Equine Botulinum Neurotoxin A Immune Fab2 | 4500 [iU]/10mL |
| Equine Botulinum Neurotoxin B Immune Fab2 | 3300 [iU]/10mL |
| Equine Botulinum Neurotoxin C Immune Fab2 | 3000 [iU]/10mL |
| Equine Botulinum Neurotoxin D Immune Fab2 | 600 [iU]/10mL |
| Equine Botulinum Neurotoxin E Immune Fab2 | 5100 [iU]/10mL |
| Equine Botulinum Neurotoxin F Immune Fab2 | 3000 [iU]/10mL |
| Equine Botulinum Neurotoxin G Immune Fab2 | 600 [iU]/10mL |
Packaging Options(2)
6 VIAL, GLASS in 1 CARTON (60492-0075-2) / 50 mL in 1 VIAL, GLASS (60492-0075-1)
1 VIAL, GLASS in 1 CARTON (60492-0075-4) / 50 mL in 1 VIAL, GLASS (60492-0075-1)